These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 7544983

  • 1. Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy.
    Taler SJ, Textor SC, Canzanello VJ, Wilson DJ, Wiesner RH, Krom RA.
    Am J Hypertens; 1995 Jun; 8(6):598-605. PubMed ID: 7544983
    [Abstract] [Full Text] [Related]

  • 2. Influence of cyclosporine A and FK506 on 24 h blood pressure monitoring in kidney transplant recipients.
    Hohage H, Brückner D, Arlt M, Buchholz B, Zidek W, Spieker C.
    Clin Nephrol; 1996 May; 45(5):342-4. PubMed ID: 8738668
    [Abstract] [Full Text] [Related]

  • 3. Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.
    Platz KP, Mueller AR, Jonas S, Blumhardt G, Bechstein WO, Lobeck H, Neuhaus HL.
    Clin Transplant; 1995 Jun; 9(3 Pt 1):146-54. PubMed ID: 7549052
    [Abstract] [Full Text] [Related]

  • 4. Blood pressure profile and treatment quality in liver allograft recipients-benefit of tacrolimus versus cyclosporine.
    Dikow R, Degenhard M, Kraus T, Sauer P, Schemmer P, Uhl W, Büchler M, Zeier M.
    Transplant Proc; 2004 Jun; 36(5):1512-5. PubMed ID: 15251373
    [Abstract] [Full Text] [Related]

  • 5. Prospective study of the circadian pattern of blood pressure after heart transplantation.
    Khot UN, Binkley PF, Haas GJ, Starling RC.
    J Heart Lung Transplant; 1996 Apr; 15(4):350-9. PubMed ID: 8732593
    [Abstract] [Full Text] [Related]

  • 6. [Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease].
    Yu LX, Shan HT, Fu SJ, Du CF, Ma JJ, Xu J, Deng WF, Wang YB.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1146-8. PubMed ID: 14625173
    [Abstract] [Full Text] [Related]

  • 7. The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?
    Mueller AR, Platz KP, Blumhardt G, Bechstein WO, Steinmüller T, Christe W, Hopf U, Lobeck H, Neuhaus P.
    Clin Transplant; 1995 Jun; 9(3 Pt 1):176-84. PubMed ID: 7549057
    [Abstract] [Full Text] [Related]

  • 8. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M, Pellegrini C, Martinelli L, Goggi C, Gavazzi A, Campana C, Arbustini E, Grossi P, Regazzi M, Ippoliti G, Vigano M.
    J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
    [Abstract] [Full Text] [Related]

  • 9. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
    Neal DA, Gimson AE, Gibbs P, Alexander GJ.
    Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583
    [Abstract] [Full Text] [Related]

  • 10. Circadian rhythm changes in blood pressure and heart rate during the first year after heart transplantation.
    Lanuza DM, Grady K, Hetfleisch M, Johnson MR.
    J Heart Lung Transplant; 1994 Jun; 13(4):614-23. PubMed ID: 7947877
    [Abstract] [Full Text] [Related]

  • 11. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R.
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [Abstract] [Full Text] [Related]

  • 12. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S, Kling N, Bechstein WO, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P.
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [Abstract] [Full Text] [Related]

  • 13. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
    Tanaka K, Lake J, Villamil F, Levy G, Marotta P, Mies S, de Hemptinne B, Moench C.
    Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691
    [Abstract] [Full Text] [Related]

  • 14. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 15. Cyclosporine-induced hypertension: evidence for maintained baroreflex circulatory control.
    Lucini D, Milani RV, Ventura HO, Mehra MR, Messerli FH, Murgo JP, Regenstein F, Copley B, Malliani A, Pagani M.
    J Heart Lung Transplant; 1997 Jun; 16(6):615-20. PubMed ID: 9229291
    [Abstract] [Full Text] [Related]

  • 16. Arterial hypertension in liver transplant recipients.
    Hryniewiecka E, Zegarska J, Paczek L.
    Transplant Proc; 2011 Oct; 43(8):3029-34. PubMed ID: 21996217
    [Abstract] [Full Text] [Related]

  • 17. The role of testosterone in cyclosporine-induced osteopenia.
    Bowman AR, Sass DA, Dissanayake IR, Ma YF, Liang H, Yuan Z, Jee WS, Epstein S.
    J Bone Miner Res; 1997 Apr; 12(4):607-15. PubMed ID: 9101372
    [Abstract] [Full Text] [Related]

  • 18. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
    Younes BS, McDiarmid SV, Martin MG, Vargas JH, Goss JA, Busuttil RW, Ament ME.
    Transplantation; 2000 Jul 15; 70(1):94-9. PubMed ID: 10919581
    [Abstract] [Full Text] [Related]

  • 19. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.
    Charco R, Cantarell C, Vargas V, Capdevila L, Lázaro JL, Hidalgo E, Murio E, Margarit C.
    Liver Transpl Surg; 1999 May 15; 5(3):204-8. PubMed ID: 10226111
    [Abstract] [Full Text] [Related]

  • 20. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct 15; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.